stella
beta
Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study — Stella
Home
/
PFO
/
Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study
View on ClinicalTrials.gov
Recruiting
Back to PFO trials
Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(5 sites)
United States
UCLA, Los Angeles, California
The Cardiac and Vascular Institute, Gainesville, Florida
Tufts Medical Center, Boston, Massachusetts
Columbia University Medical Center/ NewYork Presbyterian Hospital, New York, New York
Prisma Health - Upstate, Greenville, South Carolina